Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples

Chemical Research in Toxicology

Volumn 20, Issue 8, 2007, Pages 1177-1182

  Le Pla, Rachel C ^a   Ritchie, Kenneth J ^b   Henderson, Colin J ^b   Wolf, C Roland ^b   Harrington, Chris F ^a   Farmer, Peter B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE; OXALIPLATIN;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA ADDUCTS; MICE; MICE, KNOCKOUT; ORGANOPLATINUM COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

MUS;

EID: 34548482781     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700088j     Document Type: Article

References (25)

1. Raymond, E., Faivre, S., Chaney, S., Woynarowski, J., and Cvitkovic, E. (2002) Cellular and molecular pharmacology of oxaliplatin. Mol. Cancer Ther. 1, 227-235.
2. Almeida, G. M., Duarte, T. L., Steward, W. P., and Jones, G. D. D. (2006) Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay. DNA Repair 5, 219-225.
3. National Institute for Health and Clinical Excellence (NICE) (2005) Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Technology Appraisal 93, NICE, London.
4. Kidani, Y., Inagaki, K., Iigo, M., Hoshi, A., and Kuretani, K. (1978) Anti-tumor Activity of 1,2-Diaminocyclohexane-Platinum Complexes Against Sarcoma-180 Ascite Form. J. Med. Chem. 21, 1315-1318.
5. Reed, E., Yuspa, S. H., Zwelling, L. A., Ozols, R. F., and Poirier, M. C. (1986) Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J. Clin. Invest. 77, 545-550.
6. Reed, E., Ozols, R. F., Tarone, R., Yuspa, S. H., and Pokier, M. C. (1987) Platinum DNA adducts in leukcocyte DNA correlates with disease response in ovarian cancer patients receiving platinum based chemotherapy. Proc. Natl. Acad. Sci. U.S.A. 84, 5024-5028.
7. Reed, E., Ozols, R. F., Tarone, R., Yuspa, S. H., and Poirier, M. C. (1988) The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis 9, 1909-1911.
8. Gupta-Birt, S., Shamkhani, H., Reed, E., Tarone, R. E., Allegra, C. J., Pai, L. H., and Poirier, M. C. (1993) Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation. Cancer Epidemiol., Biomarkers Prev. 2, 229-234.
9. Parker, R. J., Gill, I., Tarone, R., Vionnet, J. A., Grunberg, S., Muggia, F. M., and Reed, E. (1991) Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis 12, 1253-1258.
10. Saris, C. P., van de Vaart, P. J. M., Rietbroek, R. C., and Blommaert, F. A. (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 17, 2763-2769.
11. Woynarowski, J. M., Faivre, S., Herzig, M. C. S., Arnett, B., Chapman, W. G., Trevino, A. V., Raymond, E., Chaney, S. G., Vaisman, A., Varchenko, M., and Juniewicz, P. E. (2000) Oxaliplatin-induced damage of cellular DNA. Mol. Pharmacol. 58, 920-927.
12. Welters, M. J. P., Maliepaard, M., Jacobs-Bergmans, A. J., Baan, R. A., Schellens, J. H. M., Ma, J. G., van der Vijgh, W. J. F., Braakhuis, B. J. M., and Fichtinger-Schepman, A. M. J. (1997) Improved P-32 postlabelling assay for the quantification of the major platinum-DNA adducts. Carcinogenesis 18, 1767-1774.
13. Wu, G.Y., Fang, Y. Z., Yang, S., Lupton, J. R., and Turner, N. D. (2004) Glutathione metabolism and its implications for health. J. Nutr. 134, 489-492.
14. Yang, P., Ebbert, J. O., Sun, Z., and Weinshilboum, R. M. (2006) Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review. J. Clin. Oncol. 24, 1761-1769.
15. Bammler, T. K., Smith, C. A. D., and Wolf, C. R. (1994) Isolation and Characterization of 2 mouse Pi-class Glutathion-S-Transferase Genes. Biochem. J. 298, 385-390.
16. Henderson, C. J., and Wolf, C. R. (2005) Disruption of the glutathione transferase Pi class genes. Methods Enzymol. 401, 116-135.
17. Bammler, T. K., Driessen, H., Finnstrom, N., and Wolf, C. R. (1995) Amino acid differences at Position 10, Position 11 and Position 104 explain the profound differences between 2 Murine Pi class Glutathione-S-Transferases. Biochemistry 34, 9000-9008.
18. McLellan, L. I., and Hayes, J. D. (1987) Sex-specific constitutive expression of the preneoplastic marker Glutathione-S-Transferase, YFYF, in mouse liver. Biochem. J. 245, 399-406.
19. Ta, L., Espeset, L., Podratz, J., and Windebank, A. J. (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27, 992-1002.
20. Weber, G., Messerschmidt, J., Pieck, A. C., Junker, A. M., Wehmeier, A., and Jaehde, U. (2004) Ultratrace voltammetric determination of DNA-bound platinum in patients after administration of oxaliplatin. Anal. Bioanal. Chem. 380, 54-58.
21. Iijima, H., Patrzyc, H. B., Dawidzik, J. B., Budzinski, E. E., Cheng, H. C., Freund, H. G., and Box, H. C. (2004) Measurement of DNA adducts in cells exposed to cisplatin. Anal. Biochem. 333, 65-71.
22. Stoehlmacher, J., Park, D. J., Zhang, W., Groshen, S., Tsao-Wei, D. D., Yu, M. C., and Lenz, H. J. (2002) Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J. Natl. Cancer Inst. 94, 936-942.
23. Adler, V., Yin, Z. M., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. (1999) Regulation of JNK signalling by GSTp. EMBO J. 18, 1321-1334.
24. Wang, T., Arifoglu, P., Ronai, Z., and Tew, K. D. (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276, 20999-21003.
25. Ishii, T., Fujishiro, M., Masuda, M., Nakajima, J., Teramoto, S., Ouchi, Y., and Matsuse, T. (2003) Depletion of glutathione S-transferase P1 induces apoptosis in human lung fibroblasts. Exp. Lung Res. 29, 523-536.